FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to infectious diseases, and concerns treating influenza. That is ensured by administering an oseltamivir antiviral preparation in combination with a rehydrone. Oseltamivir is administered 75 mg twice a day orally for 5 days. Simultaneously, daily administration of 1,000–1,500 ml of rehydron is prescribed at 100–150 ml every hour for 10–15 hours of each day for 5 days.
EFFECT: method provides effective treatment of influenza due to faster recovery of pH of oral pharyngeal mucosa and, as a result, enhanced antiviral effect of oseltamivir in places of exciter reproduction.
1 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF DEVELOPMENT OF BACTERIAL COMPLICATIONS IN PATIENTS WITH ACUTE RESPIRATORY VIRAL INFECTIONS | 2019 |
|
RU2708387C1 |
| METHOD OF PREVENTING DISEASE RECURRENCE IN PATIENTS WITH HERPES SIMPLEX | 2007 |
|
RU2354364C1 |
| METHOD FOR PREVENTING THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C AND RECEIVING COMBINATION ANTIVIRAL THERAPY | 2014 |
|
RU2568593C1 |
| METHOD FOR PREVENTION OF ANAEMIA IN PATIENTS WITH CHRONIC HEPATITIS C AND RECEIVING COMBINED ANTIVIRAL THERAPY | 2014 |
|
RU2578409C1 |
| METHOD FOR PREVENTION OF NEUTROPENIA IN PATIENTS SUFFERING CHRONIC HEPATITIS C AND RECEIVING ANTIVIRAL COMBINATION THERAPY | 2014 |
|
RU2568894C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR CHRONIC FORM OF HERPES SIMPLEX AND SUBCLINICAL CARRIER STATE OF ANTI-HERPES ANTIBODY | 2013 |
|
RU2516913C1 |
| RECURRENT ERYSIPELAS PREVENTION METHOD | 2007 |
|
RU2354144C1 |
| METHOD FOR PREDICTION OF NEUTROPENIA IN PATIENTS SUFFERING CHRONIC HEPATITIS C AND RECEIVING COMBINATION ANTIVIRAL THERAPY | 2014 |
|
RU2570342C1 |
| METHOD FOR PREDICTION OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C AND RECEIVING COMBINATION ANTIVIRAL THERAPY | 2014 |
|
RU2567818C1 |
| ANEMIA PREDICTION METHOD IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH COMBINATION ANTIVIRAL THERAPY | 2014 |
|
RU2577446C1 |
